Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn’s disease”.
Manar Askar, Seema Belani, Abdul Wali Khan, Anthony Xu, Blake Kassmeyer +16 more